129 related articles for article (PubMed ID: 6323597)
21. [Tumor selective drug delivery with lipid contrast medium (smancs/lipiodol): sustained antitumor effect, enhanced diagnostic value and quantification of dosage regimen].
Maeda H; Konno T; Iwai K; Maki S; Tashiro S
Gan To Kagaku Ryoho; 1984 Apr; 11(4):814-26. PubMed ID: 6326681
[TBL] [Abstract][Full Text] [Related]
22. [Histological effect of SMANCS/LPD therapy in renal cell carcinoma].
Suzuki T; Kobayashi M; Nakamura T; Takahashi O; Imai K; Yamanaka H; Suzuki K; Konno T; Maeda H
Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2210-7. PubMed ID: 2833546
[No Abstract] [Full Text] [Related]
23. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications].
Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690
[TBL] [Abstract][Full Text] [Related]
24. [Computed tomography after administration of SMANCS-lipiodol to liver cancers].
Maki S; Konno T; Iwai K; Uchida M; Tashiro S; Miyauchi Y; Maeda H
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1443-9. PubMed ID: 6097616
[No Abstract] [Full Text] [Related]
25. [Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome].
Maeda H; Konno T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):773-82. PubMed ID: 2985005
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma].
Inoue Y; Tomoda K; Oi H; Nakamura H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689
[TBL] [Abstract][Full Text] [Related]
27. [Prevention of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein].
Yamasaki K; Konno T; Miyauchi Y; Maeda H
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1224-8. PubMed ID: 3034169
[TBL] [Abstract][Full Text] [Related]
28. [CT image of the liver cancer after administration of SMANCS/lipiodol].
Maki S; Konno T; Iwai K; Tashiro S; Otsuka N; Yamasaki K; Mizutani J; Miyauchi Y; Maeda H; Yokoyama I
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1603-10. PubMed ID: 3015036
[TBL] [Abstract][Full Text] [Related]
29. [Our initial experience with SMANCS in TAE for liver cancer].
Fujita M; Inoue E; Kuroda C; Kasugai H; Sasaki Y; Nakano H; Imaoka S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697
[TBL] [Abstract][Full Text] [Related]
30. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
[TBL] [Abstract][Full Text] [Related]
31. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma--second report].
Hirashima N; Itazu I; Nukaya H; Kimura H; Hasegawa I; Yoshimizu T; Nemoto S; Sakakibara K
Gan To Kagaku Ryoho; 1998 May; 25(6):873-9. PubMed ID: 9617326
[TBL] [Abstract][Full Text] [Related]
32. [A case of giant hepatocellular carcinoma successfully treated by arterial administration of SMANCS].
Yajima Y; Miyazaki A; Miyasato S; Tomiya Y; Shibuya D; Ohira S; Sakurada H; Ishii K; Kinoshita T
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1325-9. PubMed ID: 8831747
[TBL] [Abstract][Full Text] [Related]
33. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of malignant renal tumor with intra-arterial administration of oily anticancer drugs].
Konno S; Tanaka J; Urabe D; Miyazaki F; Noda S; Maeda H; Konno T
Nihon Hinyokika Gakkai Zasshi; 1984 Dec; 75(12):1874-82. PubMed ID: 6100120
[No Abstract] [Full Text] [Related]
35. Treatment of renal cell carcinoma with intra-arterial administration of SMANCS dissolved in Lipiodol.
Noda S; Konno S; Tanaka J; Yamada M; Yoshitake N
Anticancer Res; 1990; 10(3):709-15. PubMed ID: 2164351
[TBL] [Abstract][Full Text] [Related]
36. Successful arterial administration therapy of SMANCS for liver metastasis of malignant insulinoma.
Igarashi H; Ito T; Ogoshi K; Kuroiwa T; Koyanagi S; Arita Y; Sumii T; Nawata H
Pancreas; 1999 Aug; 19(2):207-10. PubMed ID: 10438170
[No Abstract] [Full Text] [Related]
37. Clinical evaluation of arterial administration of SMANCS in oily contrast medium for liver cancer.
Tashiro S; Maeda H
Jpn J Med; 1985 Feb; 24(1):79-80. PubMed ID: 2987585
[No Abstract] [Full Text] [Related]
38. [Comparative studies on the antitumor activities and side effects of segmental SMANCS/Lip-TAE with segmental SMANCS/Lip-TAI for hepatocellular carcinoma].
Matoba M; Okimura T; Yamamoto I
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():73-9. PubMed ID: 9512692
[TBL] [Abstract][Full Text] [Related]
39. [Efficiency of segmental SMANCS/Lip-TAE for hepatocellular carcinoma--comparative studies in the efficacy of segmental SMANCS/Lip-TAI].
Matoba M; Mitsuya T; Ichiyanagi K; Morita M; Kidani E; Ibe N; Tatsumi Y; Tamamura H; Nakagawa T; Okimura T; Yamamoto I
Gan To Kagaku Ryoho; 1997 Jan; 24(1):37-42. PubMed ID: 9020943
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of hepatic artery occlusion after intra-arterial infusion of SMANCS in patients with hepatocellular carcinoma].
Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Oct; 58(12):700-4. PubMed ID: 9844406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]